Approval · Notice of Compliance 4801 · 2004

PLAN B: Notice of Compliance 4801

Issued July 15, 2004

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 4801
Date: July 15, 2004
Company: Duramed Pharmaceuticals, Inc., A Subsidiary Of Barr Pharmaceuticals, Inc.
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Emergency contraception

Products in this notice

Brand	DIN	Status today
PLAN B	02241674	Cancelled Post Market

Medicinal ingredients

LEVONORGESTREL 0.75 MG per TAB